Home >> Tag Archives: Sekisui Diagnostics—

Tag Archives: Sekisui Diagnostics—

Sekisui Diagnostics, Qualigen partnership, 10/16

October 2016—Sekisui Diagnostics and Qualigen announced a strategic partnership encompassing current business and future collaboration opportunities. Sekisui Diagnostics has assumed commercial activities and distribution management for the FastPack IP System and associated products in U.S. and international markets.

Read More »

Clinical chemistry reagents, 8/15

Sekisui Diagnostics launched the Sekure brand of clinical chemistry reagents. Sekisui develops, manufactures, and supplies clinical chemistry reagents and systems to the in vitro diagnostics industry, selling more than 1.5 billion clinical chemistry tests per year.

Read More »

Sekisui launches line of clinical chemistry reagents

July 10, 2015—Sekisui Diagnostics recently announced the launch of its new Sekure brand of clinical chemistry reagents. Sekisui is develops, manufactures, and supplies clinical chemistry reagents and systems to the in vitro diagnostics industry, selling more than 1.5 billion clinical chemistry tests per year. In a statement, the company said it aims to supply customers and patients with products they ...

Read More »

Fecal occult blood test, 6/13:96

Sekisui Diagnostics’ OSOM rapid immunochemical fecal occult blood test detects hemoglobin in stool samples as an aid in the early detection of colorectal cancer. The OSOM test provides sample stability: a unique “dry-sample” collection card; value: two patient sample collections on one collection card allow compliance with screening guidelines, using only one test cassette; and a comprehensive physician and patient support Web site.

Read More »
X